Taofeek Owonikoko

Professor and Division Chief

University of Pittsburgh

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Jennifer W Carlisle

Winship Cancer Institute of Emory University

UNITED STATES

View details

Guoqing Qian

Assistant Professor

The University of Texas Health Science Center at Tyler

UNITED STATES

View details

Julie E. Bauman

The George Washington University School of Medicine and Health SCiences

UNITED STATES

View details

Shi-Yong Sun

Professor

Emory University

UNITED STATES

View details

Dong M. Shin

Professor

Emory University

UNITED STATES

View details

Paul Nghiem

Professor

University of Washington

UNITED STATES

View details

Jeffrey Switchenko

Emory University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Taofeek Owonikoko

Research Interests

Explore related searches

Contact this professor

Articles (10)

Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast

Cisplatin-Induced Ototoxicity: A Concise Review of the Burden, Prevention, and Interception Strategies

Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer

Concurrent Androgen Deprivation Therapy for Prostate Cancer Improves Survival for Synchronous or Metachronous Non-Small Cell Lung Cancer: A SEER–Medicare Database Analysis

A Multicenter Randomized Phase II Study of Single Agent Efficacy and Optimal Combination Sequence of Everolimus and Pasireotide LAR in Advanced Thyroid Cancer

Assessment of hyperprogression versus the natural course of disease development with nivolumab with or without ipilimumab versus placebo in phase III, randomized, controlled trials

Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both

Membrane-Associated RING-CH 8 Functions as a Novel PD-L1 E3 Ligase to Mediate PD-L1 Degradation Induced by EGFR Inhibitors

Induction of SREBP1 degradation coupled with suppression of SREBP1-mediated lipogenesis impacts the response of EGFR mutant NSCLC cells to osimertinib

Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib

Collaborators (7)

Jennifer W Carlisle

Guoqing Qian

Julie E. Bauman

Shi-Yong Sun

Dong M. Shin

Paul Nghiem

Jeffrey Switchenko

Make your next move.